BAC
Bank of America Corporation
BAC has a slight edge over FBNC overall, supported by stronger valuation and stronger modeled upside.
FBNC
First Bancorp
FBNC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FBNC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
FBNC's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like FBNC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FBNC in the historical PE scenario, which offers more potential upside but is not a forecast.
FBNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $37.47 | -42% |
| Fair | 13x | $51.23 | -21% |
| Forward | 13x | $64.80 | — |
| Current | 16x | $64.80 | — |
| Expensive | 20x | $79.73 | +23% |
Historical ranges are pointers, not guarantees.
FBNC's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FBNC on the outlook, with more favorable profitability expectations.
FBNC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FBNC, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FBNC on earnings, with more consistent year-over-year improvement.
FBNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.82 | +21% |
| Q3 2026 | $3.97 | +67% |
| Q2 2026 | $3.22 | +38% |
| Q1 2026 | $2.93 | +39% |
| Q4 2025 | $2.68 | +46% |
| Q3 2025 | $2.38 | -4% |
| Q2 2025 | $2.34 | -15% |
| Q1 2025 | $2.11 | -24% |
| Q4 2024 | $1.84 | -27% |
FBNC earned $3.97 per share over the past year, up 67% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FBNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $129.9M | +45% |
| Q2 2026 | $127.3M | +15% |
| Q1 2026 | $122.3M | +16% |
| Q4 2025 | $83.9M | +28% |
| Q3 2025 | $89.6M | -7.3% |
| Q2 2025 | $111M | +16% |
| Q1 2025 | $105.8M | +15% |
| Q4 2024 | $65.7M | -32% |
FBNC's revenue has grown year over year for four quarters in a row: $130M last quarter, up 45% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +21 points |
| Q2 2026 | 50% | +4.9 points |
| Q1 2026 | 48% | +4 points |
| Q4 2025 | 20% | +9.7 points |
| Q3 2025 | 29% | +5.6 points |
| Q2 2025 | 45% | +6.4 points |
| Q1 2025 | 44% | +9.7 points |
| Q4 2024 | 10% | -28 points |
FBNC has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FBNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $98M | +103% |
| Q2 2026 | $65.5M | +48% |
| Q1 2026 | $59.3M | +13% |
| Q4 2025 | $54M | -21% |
| Q3 2025 | $48.2M | +27% |
| Q2 2025 | $44.3M | -49% |
| Q1 2025 | $52.4M | +$74.1M |
| Q4 2024 | $68.2M | +54% |
FBNC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FBNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FBNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +18.4K shares |
| 1 year | -0.2% | -87.8K shares |
| 3 years | +0.5% | +195K shares |
| 5 years | +45% | +12.9M shares |
| Available history | +39% | +11.7M shares |
FBNC has 41M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.1M |
| Q1 2026 | $5.1M |
| Q4 2025 | $1,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $992,000 |
| Q4 2022 | — |
FBNC spent $7M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FBNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 0.1x | Very low |
FBNC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FBNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 65.3 | Neutral |
FBNC's weekly RSI is 58 (neutral) and its Stochastic is 65 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over FBNC on valuation relative to its sector.
FBNC PE vs Financial Services Sector
| Metric | FBNC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 25% above |
| PE % | 71 | 63 | 8 pts above |
FBNC is trading at 16x earnings, a 25% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FBNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 3.1% above |
| 20 week MA | $63.6 | 1.8% above |
| 50 week MA | $59.8 | 8.4% above |
| 100 week MA | $52.7 | 23% above |
| 200 week MA | $44.0 | 47% above |
FBNC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FBNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.1 | $33.5 | -16% |
| 2021 | $33.5 | $45.1 | +35% |
| 2022 | $45.1 | $43.4 | -3.9% |
| 2023 | $43.4 | $37.0 | -15% |
| 2024 | $37.0 | $44.4 | +20% |
| 2025 | $44.4 | $52.1 | +17% |
| 2026 YTD | $52.1 | $64.8 | +24% |
FBNC has the edge over BAC on returns for 2026, with the stronger performance.